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Latent infection with Epstein-Barr virus (EBV) is responsible for multiple types of malignancies, including 10% of all gastric car-
cinomas. The microRNA (miRNA) expression in several EBV-infected AGS gastric carcinoma cell lines was determined. Infected
cells expressed the viral BamHI A rightward transcript (BART) miRNAs at high levels and had consistently decreased expression
of a small fraction of cellular miRNAs with specific downregulation of tumor suppressor miRNAs. These changes likely reflect
expression of the viral noncoding RNAs and not latent protein expression.
Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus inwhich latent infection is associated with a number of malig-
nancies, including multiple types of B-cell lymphomas, nasopha-
ryngeal carcinoma (NPC), and gastric carcinoma (GC) (1, 2). EBV
expresses a diverse subset of latent proteins with oncogenic poten-
tial in lymphomas in immunocompromised patients but a much
more restricted set of viral proteins in malignancies in patients
with intact immune systems. In addition, EBV expresses multiple
noncoding RNAs during all types of latency, including two clus-
ters of microRNAs (miRNAs). The largest set of miRNAs, the
BamHI A rightward transcript (BART) miRNAs, are 44 miRNAs
processed from the introns of the BARTs that are expressed at high
levels in EBV epithelial malignancies (3–5). Infection of the gastric
carcinoma cell line, AGS, with EBV has recently been shown to
induce a more transformed phenotype, with dramatic changes in
the cellular expression profile despite the expression of only one
latent viral protein, EBNA1, to any significant level (6). A signifi-
cant fraction of the changes in cellular expression likely reflect
expression of the BART RNAs (6).
To profile the expression pattern of the BART miRNAs in in-
fected AGS cells, five additional clonally infected lines were estab-
lished by incubation of induced Akata-BX1 cells with uninfected
AGS cells and selection for green fluorescent protein (GFP)-pos-
itive, G418-resistant clones. The viral protein expression pattern
was determined by Western blotting and was nearly identical to
that of the original cell line, with expression of only EBNA1 at a
significant level (Fig. 1A). A small and somewhat variable amount
of LMP1, which has previously been shown to not affect cellular
gene expression, was expressed in these cell lines (6). Analysis of
EBER expression by using quantitative reverse transcription
(RT)-PCR that amplifies a conserved region revealed that all six
EBV-infected AGS cell lines (AGS-EBV) expresses both EBER1
and EBER2, with consistently higher levels of EBER2 than are
expressed by the Jijoye lymphoid cell line (Fig. 1B). Importantly,
each clone had improved colony formation in soft agar, indicating
that the transformed phenotype of latent EBV infection in this cell
line was highly reproducible (Fig. 1C and D).
To profile the expression level of the viral miRNAs in these cell
lines, small-RNA libraries were created using an Illumina TrueSeq
small-RNA sample preparation kit and sequenced on a HiSeq
2000 sequencing system. The libraries are specific for miRNAs, as
the RNAs are selected for size and the 3= adapter is specific for
RNA containing a 3= hydroxyl group characteristic of miRNAs. In
total, eight libraries were sequenced, two libraries from the paren-
tal AGS cell line, two libraries from the original AGS-EBV cell line,
and one library each from new clones 1 and 2, as well as a library
from the NPC cell line C666 and one from the NPC xenograft C15
for comparison. After processing was performed to remove
adapter sequences, reads were aligned to the human (hg19) and
viral (NC_007605) genomes using the Bowtie short read aligner.
Confirming the size selection, the vast majority of reads were 20 to
24 bases. Reads of 16 to 25 nucleotides in length that overlapped
by at least 16 nucleotides with mature miRNA coordinates ob-
tained from miRBASE were counted as miRNA reads in the anal-
ysis in order to not exclude miRNAs with differential 5= and 3=
processing, which is common in EBV miRNAs (Table 1) (7). A
small fraction of the reads from the parental cells aligned to the
EBV genome, although most were extremely short reads and likely
nonspecific. However, very low levels of authentic EBV miRNAs
were detected in these samples. It is not clear if this is due to some
minor level of contamination during sample preparation or a low
level of background EBV infection in the parental cell line. The
numbers of total reads and miRNAs sequenced are shown in
Table 1.
Each of the EBV-infected cell lines had a large fraction of their
total miRNA pool derived from the virus, with 57% of all miRNAs
in the C15 NPC tumor encoded by EBV (Fig. 2). The AGS-EBV
cell lines have an expression pattern consistent with the pattern of
the NPC cells and other epithelial EBV malignancies in which the
BART miRNAs are very highly expressed and the BHRF1 miRNAs
are rarely expressed (3). Expression of the BHRF1 miRNAs was
essentially negligible in the C15 and C666 NPC samples, while a
few hundred reads were detected in the AGS-EBV cells (see Data
Set S1 in the supplemental material). As these miRNAs have been
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shown to increase upon induction of viral replication, the BHRF1
miRNA reads may be due to expression in a small subset of cells
with permissive infection. Overall, the pattern of abundance of the
individual BART miRNAs was quite consistent across the AGS-
EBV clones and the NPC samples, suggesting similar processing in
these different cell types. However, this pattern of BART abun-
dance is distinct from that reported in other profiling studies done
in NPC, and there is little consistency for one pattern of BART
miRNA abundance in the literature (5, 7–9). This may reflect dif-
ferences in techniques and informatics between studies.
In order to determine whether there were any changes in the
abundance of cell-derived miRNAs in response to EBV infection
of AGS cells, the aligned human sequences were imported into the
Partek genomic suite software, which was used to calculate signif-
icant changes in human miRNA levels. miRNA changes with a P
value of 0.05 were considered significant, while those that rep-
FIG 1 Multiple clonal infections of AGS cells are anchorage independent with restricted viral expression. (A) Western blot for latent viral protein expression in
AGS-EBV clonal cell lines. The five new clones are compared to the original AGS-EBV cell line, to parental cells as a negative control (AGS), and to a type III
Burkitt’s lymphoma as a positive control (Jijoye). Western blots were probed with anti-LMP1 (S12 hybridoma supernatant), anti-LMP2 (clone 14B7; abcam),
anti-EBNA1 (OT1x monoclonal antibody), anti-EBNA2 (PE2 monoclonal antibody), or anti-HSC70 (Santa Cruz; sc-7298) as a loading control. An overexposed
lane of LMP1 is shown to demonstrate the small amount of LMP1 present in some of the cell lines. (B) Quantitative RT-PCR for EBER expression in AGS-EBV
cells. The bars represent the average EBER expression levels across two RNA preparations from each of the six AGS-EBV cell lines relative to the average from
three independent RNA preparations from Jijoye cells. PCR was performed with the Qiagen Quantifast SYBR green RT-PCR kit and the following primers:
EBER1, 5=-ACCTACGCTGCCCTAGAGGT and 3=-TGGGAAGACAACCACAGACA; EBER2, 5=-GGAGGAGAAGAGAGGCTTCC and 3=-ATAGCGGACAAG
CCGAATAC. (C and D) Soft agar assay of AGS-EBV cells. Cells were seeded in F12 medium with 0.5% Bacto agar and allowed to grow for 10 days. Colonies were
then stained with 0.005% crystal violet and scored for growth (C) or photographed at 100 magnification (D). AGS cells infected with EBV grow larger colonies
in soft agar, with a lack of the hollow, aborted colonies seen in the parental cells. An example of an aborted colony is indicated by an arrow in panel D. All five new
clones of infected cells show similar phenotypes of increased anchorage-independent growth.
TABLE 1 Summary of small-RNA sequencing results
Library
No. of reads No. of miRNAs
% viral miRNAsTotal Mapped to human Mapped to EBV Human EBV
Parental AGS 1 35,111,900 33,305,259 445,435 22,884,865 7,705 0.03
Parental AGS 2 19,200,981 18,250,058 1,343,213 14,988,219 5,134 0.03
AGS-EBV 1 56,873,929 51,935,642 4,317,658 41,696,846 3,913,670 8.58
AGS-EBV 2 24,244,558 21,212,801 4,529,355 16,841,905 2,484,335 12.85
Clone 1 30,010,016 24,889,072 5,441,869 18,042,838 4,060,515 18.37
Clone 2 23,432,180 19,467,911 5,176,603 12,263,106 3,163,597 20.51
C666 24,241,258 18,475,830 7,185,207 8,748,402 5,693,242 39.42
C15 37,510,160 29.354.352 11,383,451 3,076,020 4,137,077 57.36
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resented less than 0.05% of the total pool were excluded. A small
subset of the human miRNAs was downregulated upon EBV in-
fection, with no miRNAs increased by infection. Interestingly, the
downregulated miRNAs included several miRNAs that act as tu-
mor suppressors (see Data Set S1 in the supplemental material).
The miRNA expression profile of the two NPC line sequences was
substantially different from that of the AGS cells. It is likely that
the considerable differences in the cellular miRNA profiles be-
tween AGS-EBV and the C15 NPC may reflect the contribution of
viral proteins expressed in the C15 NPC tumor, including abun-
dant LMP1.
To confirm these findings and expand the number of samples
tested, Exiqon miRNA PCR arrays were performed. A total of 10
arrays were performed using three unique preparations of paren-
tal AGS RNA, two from the original AGS-EBV cell line, and one
each from the five individual clones of AGS-EBV cells (see Data
Set S2 in the supplemental material). The data from the PCR ar-
rays largely confirmed the sequencing data, with many of the same
miRNAs downregulated in response to EBV infection (Table 2).
The fold changes tended to be larger with the PCR method than
with the sequencing method, which may reflect normalization to
housekeeping genes for the PCR data whereas the sequencing data
are normalized to the total human miRNA pool. This result would
also be consistent with EBV infection’s decreasing the overall
abundance of human miRNAs, perhaps due to competition for
processing with the viral miRNAs or reported effects on Dicer
function (10). Two miRNA families, the let-7 family and the miR-
200 family, both of which are known tumor suppressor families,
were heavily represented in the downregulated miRNAs (11, 12).
These findings confirm previous findings indicating decreased ex-
pression of the miR-200 family of miRNAs in EBV-infected AGS
cells and the observation that the levels of miR-200 family mem-
bers are lower in EBV-positive GCs than in EBV-negative GCs (13,
14). Both methods of profiling indicated that miR-143, which has
also been shown to act as a tumor suppressor in a number of
different types of cancer, was significantly decreased (15–17).
To evaluate the potential effects of viral protein expression on
host tumor suppressor miRNAs, EBNA1, the one viral protein
significantly expressed in AGS cells, was overexpressed in unin-
fected AGS cells and the effects on a subset of the cellular tumor
suppressor miRNAs was assessed using quantitative RT-PCR (Fig.
3A). Expression of EBNA1 at substantially higher levels than that
of EBV-infected cells reduced miR-143 levels but did not affect the
five other miRNAs tested (Fig. 3B). To ensure that the trace levels
of LMP1 expressed in these cells was not responsible for the de-
creased expression of the tumor suppressor miRNAs, a dominant
negative LMP1 was overexpressed to inhibit any residual LMP1
FIG 2 EBV miRNA counts from small-RNA libraries. The number of sequencing reads mapped to the mature miRNAs of EBV is indicated per 10 million total
miRNAs to normalize for sequencing depth in each library. The value displayed for AGS-EBV is an average of results for four sequencing libraries, two from the
original AGS-EBV cell line and one each from the first two newly made clones. The inset displays the relative contribution of EBV to the total pool of miRNAs
from each of the cell lines. Again, the value for the AGS-EBV cells is an average of results for four samples, with the standard error of the mean indicated by error
bars.




P value Fold change P value Fold change
let-7 family
hsa-let-7a-5p 0.0397 2.226 0.0442 1.608
hsa-let-7b-5p 0.0533 1.912 0.0135 2.555
hsa-let-7f-5p 0.0434 1.696 0.1935 1.681
hsa-mir-98-5p 0.0471 2.219 0.0617 3.566
miR-200 family
hsa-miR-200a-3p 0.1446 1.624 0.0133 2.315
hsa-miR-200b-3p 0.0225 1.757 0.0352 2.498
hsa-miR-200c-3p 0.0480 1.684 0.0328 1.857
hsa-miR-429 0.0717 1.838 0.0195 2.591
Others
hsa-miR-143-3p 0.1416 2.974 0.0014 6.090
hsa-miR-146b-5p 0.1337 1.954 0.0234 4.106
hsa-miR-148a-3p 0.0760 1.997 0.0087 3.135
hsa-miR-181b-5p 0.1252 2.004 0.0400 2.589
hsa-miR-23a-3p 0.0080 1.840 0.0261 2.073
hsa-miR-24-3p 0.1091 1.945 0.0336 1.807
hsa-miR-27a-3p 0.0149 1.345 0.0350 1.980
hsa-miR-29a-3p 0.0345 1.343 0.0226 2.318
hsa-miR-92b-3p 0.1022 1.843 0.0482 2.305
a miRNA changes were considered highly confident with a P value of 0.05 by one
method and showed a confirmatory change with a P value of  0.20 by the other
method. miRNAs that represent 0.05% of the total pool (based on sequencing data)
were excluded.
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function in the AGS-EBV cells (Fig. 3C) (18). Inhibition of LMP1
did not increase expression of any of the miRNAs tested (Fig. 3D).
These results suggest that latent EBV infection modulates the
expression pattern of a subset of host miRNAs largely through
a mechanism that is independent of latent protein expression.
Although it is likely that a variable number of cells in each of
the infected cell lines has some expression of replicative genes, the
consistent effects on cellular miRNA expression suggest that the
changes occur in the majority of cells which are latently infected.
Given the dramatic level of EBV BART miRNA expression, it is
possible that these host miRNA levels are changed as a secondary
effect of EBV miRNAs on expression of transcriptional regulators.
Additionally, other EBV noncoding RNAs such as the EBERs may
contribute to these effects. Taken together, the data presented
demonstrate a significant shift in the total miRNA pool in epithe-
lial cells infected with EBV with very restricted viral protein ex-
pression. These changes include both a decrease in host tumor
suppressor miRNAs and elevated expression of viral miRNAs with
demonstrated oncogenic potential.
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